New therapeutic approaches in primary IgA nephropathy.
Locatelli
F
F
Department of Nephrology and Dialysis, Ospedale di Lecco, Italy.
Pozzi
C
C
Del Vecchio
L
L
Andrulli
S
S
Bolasco
P
P
Fogazzi
G
G
Altieri
P
P
Ponticelli
C
C
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D004359:Drug Therapy, Combination; D005395:Fish Oils / Q000627:therapeutic use; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D009398:Nephrology / Q000639:trends*; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013256:Steroids / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005395:Fish Oils; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013256:Steroids